We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics
Gold Supplier
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Diagnostic Salivary DHEA ELISA Kit
Salimetrics Salivary DHEA Enzyme Immunoassay Kit
Immunoassay Analyzer
DxI 9000
Visit expo >

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Image: The test detects MTB in a saliva matrix using the GEO platform (Photo courtesy of ReadyGo Diagnostics)

MTB Screening Test Could Replace Smear Microscopy with Saliva Sample

A breakthrough in the detection of Mycobacterium Tuberculosis (MTB) paves the way for affordable testing that could have a profound impact on MTB eradication efforts in heavily affected countries across the world. More...
06 Jun 2023
Image: The global HbA1c testing devices market is expected to reach USD 2.56 billion in 2027 (Photo courtesy of Freepik)

Global Hemoglobin A1c Testing Devices Market Driven by Rising Prevalence of Diabetes

The global HbA1c testing devices market is projected to expand at a CAGR of 10.3%, from USD 1.72 billion in 2023 to USD 2.56 billion in 2027, driven mainly by the rising prevalence of diabetes and other lifestyle diseases. More...
06 Jun 2023
Image: The Coris acquisition provides Avacta with a broad, professional-use rapid test product portfolio (Photo courtesy of Coris Bioconcept)

Avacta Expands Diagnostics Portfolio with Acquisition of Rapid Test Maker Coris Bioconcept

Avacta Group has acquired Coris Bioconcept for an upfront cash consideration of GBP 7.4 million, including an earnout, contingent on future business performance, which could amount to up to GBP 3 million in cash. More...
05 Jun 2023
Image: Galleri Multi-Cancer Test (Photo courtesy of GRAIL)

Blood Test for Symptomatic Patients Aims to Revolutionize Cancer Diagnosis

A novel blood test, capable of detecting over 50 types of cancer, has shown promising results, accurately detecting cancer in two-thirds of more than 5,000 individuals who had consulted their physician due to suspected symptoms. More...
05 Jun 2023
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process. More...
02 Jun 2023
Image: Highly sensitive Raman probe detects enzyme expression in heterogeneous tissues (Photo courtesy of Tokyo Tech)

Raman Imaging Probes for Detecting Enzyme Activities Could Aid Disease Diagnosis

By developing 9CN-rhodol-based activatable Raman probes using a novel mechanism for Raman signal activation, researchers have demonstrated that Raman imaging offers greater potential for detecting multiple enzyme activities than fluorescence imaging. More...
02 Jun 2023
Image: A portable smartphone-based POC device for use with EXTRA-CRISPR method for cancer diagnostics (Photo courtesy of UF Health)

CRISPR-Powered Method for Non-Invasive Blood Tests to Help Diagnose Early Stage Cancer

Earlier CRISPR tests were not as sensitive as the gold standard RT-qPCR and involved multistep reactions with manual handling. Now, a new approach, called “EXTRA-CRISPR,” could represent a game-changing method in the microRNA testing field. More...
02 Jun 2023
Copyright © 2000-2023 Globetech Media. All rights reserved.